Technical analysis of Azitra, Inc. (AZTR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strain of S. epidermidis intended to treat Netherton syndrome, a specific skin disorder. ATR-04: Another modified S.
Price Performance
| 1 month | +29.92% |
| 3 months | -5.42% |
| Year-to-date | -38.67% |
| 1 year | -79.16% |
| 3 years | -99.96% |
52-Week Range
| 52-week High | $1.09 |
| 52-week Low | $0.10 |
| Avg Volume (90d) | 8.8M |
Technical Indicators
| SMA 50 | $0.15 |
| SMA 200 | $0.21 |
| Beta | -2.17 |
| 30-day Volatility (annualised) | 69.6% |
| Price vs SMA 50 | +9.8% |
| Price vs SMA 200 | -24.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $0.52 | |
| 2025-11 | $0.38 | -27.9% |
| 2025-12 | $0.26 | -29.8% |
| 2026-01 | $0.24 | -7.7% |
| 2026-02 | $0.17 | -28.4% |
| 2026-03 | $0.23 | +33.7% |
| 2026-04 | $0.25 | +5.2% |
| 2026-05 | $0.23 | -6.6% |
| 2026-06 | $0.17 | -27.0% |
| 2026-07 | $0.13 | -20.9% |
| 2026-08 | $0.17 | +31.9% |
| 2026-09 | $0.16 | -7.2% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $0.03 | $1M |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
Price
| Price | $0.16 |
| Market Cap | $2M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 0.41 |
| EV / EBITDA | 0.84 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.06 |
| Current Ratio | 4.86 |